Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CDRH offices move

This article was originally published in The Gray Sheet

Executive Summary

Center for Devices and Radiological Health's Office of Device Evaluation and Office of the Center Director relocation to 9200 Corporate Boulevard in Gaithersburg, Maryland from 1390 Piccard Drive will occur in October, FDAers say. The move was initially slated to occur in June ("The Gray Sheet" Jan. 3, p. 34). ODE's Division of Clinical Laboratory Devices recently moved to 2098 Gaither Road from 1390 Piccard, and the Office of Surveillance and Biometrics' Division of Biostatistics is slated to move to 1390 Piccard on Aug. 27. The division is newly created with the disbanding of the Division of Biometric Sciences ("The Gray Sheet" Aug. 8, In Brief). The Office of Management Services and portions of the Office of Health Industry Programs will move to 1350 Piccard this fall from their current Rockville, Maryland addresses

You may also be interested in...

'Purple Drank' Drug Cocktail Linked To France's Latest Reverse-Switch

Promethazine has been reverse-switched from OTC to prescription status in France, with rising abuse of the drug in the so-called Purple Drank cocktail one of the motivating factors for the move by the country's health ministry.

P&G Causes Friction With UK Cosmetics Firm Over Ad Claim

Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.

UK Readies Medtech And Pharma Sectors For Regulatory Life Outside The EU

Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts